829 related articles for article (PubMed ID: 30819375)
21. The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure.
Schou M; Gustafsson F; Corell P; Kistorp CN; Kjaer A; Hildebrandt PR
Am Heart J; 2007 Jul; 154(1):123-9. PubMed ID: 17584564
[TBL] [Abstract][Full Text] [Related]
22. Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death.
Jia X; Al Rifai M; Hoogeveen R; Echouffo-Tcheugui JB; Shah AM; Ndumele CE; Virani SS; Bozkurt B; Selvin E; Ballantyne CM; Nambi V
JAMA Cardiol; 2023 Mar; 8(3):222-230. PubMed ID: 36753229
[TBL] [Abstract][Full Text] [Related]
23. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
24. Relationship between N-terminal pro-brain natriuretic peptide, obesity and the risk of heart failure in middle-aged German adults.
Wirth J; Buijsse B; di Giuseppe R; Fritsche A; Hense HW; Westphal S; Isermann B; Boeing H; Weikert C
PLoS One; 2014; 9(11):e113710. PubMed ID: 25423197
[TBL] [Abstract][Full Text] [Related]
25. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of depressive symptoms and B-type natriuretic peptide for new-onset heart failure and mortality.
van den Broek KC; Defilippi CR; Christenson RH; Seliger SL; Gottdiener JS; Kop WJ
Am J Cardiol; 2011 Mar; 107(5):723-9. PubMed ID: 21316507
[TBL] [Abstract][Full Text] [Related]
27. Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register.
Eriksson B; Wändell P; Dahlström U; Näsman P; Lund LH; Edner M
Scand J Prim Health Care; 2019 Dec; 37(4):434-443. PubMed ID: 31724475
[No Abstract] [Full Text] [Related]
28. C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.
Koller L; Kleber M; Goliasch G; Sulzgruber P; Scharnagl H; Silbernagel G; Grammer T; Delgado G; Tomaschitz A; Pilz S; März W; Niessner A
Eur J Heart Fail; 2014 Jul; 16(7):758-66. PubMed ID: 24806206
[TBL] [Abstract][Full Text] [Related]
29. Association of beta-hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort.
Flores-Guerrero JL; Westenbrink BD; Connelly MA; Otvos JD; Groothof D; Shalaurova I; Garcia E; Navis G; de Boer RA; Bakker SJL; Dullaart RPF
Eur J Clin Invest; 2021 May; 51(5):e13468. PubMed ID: 33616911
[TBL] [Abstract][Full Text] [Related]
30. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
[TBL] [Abstract][Full Text] [Related]
32. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
[TBL] [Abstract][Full Text] [Related]
33. N-terminal pro-B-type natriuretic peptide and the risk of stroke and transient ischaemic attack: the Rotterdam Study.
Portegies ML; Kavousi M; Leening MJ; Bos MJ; van den Meiracker AH; Hofman A; Franco OH; Koudstaal PJ; Ikram MA
Eur J Neurol; 2015 Apr; 22(4):695-701. PubMed ID: 25573143
[TBL] [Abstract][Full Text] [Related]
34. Contrasting association between alcohol consumption and risk of myocardial infarction and heart failure: Two prospective cohorts.
Larsson SC; Wallin A; Wolk A
Int J Cardiol; 2017 Mar; 231():207-210. PubMed ID: 28043668
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of C-reactive protein as an inflammatory and N-terminal probrain natriuretic peptide as a neurohumoral marker in acute heart failure (from the Korean Heart Failure registry).
Park JJ; Choi DJ; Yoon CH; Oh IY; Jeon ES; Kim JJ; Cho MC; Chae SC; Ryu KH; Yoo BS; Kang SM; Oh BH;
Am J Cardiol; 2014 Feb; 113(3):511-7. PubMed ID: 24315115
[TBL] [Abstract][Full Text] [Related]
36. Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.
Ballo P; Betti I; Barchielli A; Balzi D; Castelli G; De Luca L; Gheorghiade M; Zuppiroli A
Clin Res Cardiol; 2016 May; 105(5):421-31. PubMed ID: 26547915
[TBL] [Abstract][Full Text] [Related]
37. N-terminal pro-B-type natriuretic peptide in chronic heart failure: The impact of sex across the ejection fraction spectrum.
Faxén UL; Lund LH; Orsini N; Strömberg A; Andersson DC; Linde C; Dahlström U; Savarese G
Int J Cardiol; 2019 Jul; 287():66-72. PubMed ID: 31005415
[TBL] [Abstract][Full Text] [Related]
38. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
[TBL] [Abstract][Full Text] [Related]
39. Relation of Kidney Function Decline and NT-proBNP With Risk of Mortality and Readmission in Acute Decompensated Heart Failure.
McCallum W; Tighiouart H; Kiernan MS; Huggins GS; Sarnak MJ
Am J Med; 2020 Jan; 133(1):115-122.e2. PubMed ID: 31247182
[TBL] [Abstract][Full Text] [Related]
40. High-Sensitivity Cardiac Troponin I Levels and Prediction of Heart Failure: Results From the BiomarCaRE Consortium.
Yan I; Börschel CS; Neumann JT; Sprünker NA; Makarova N; Kontto J; Kuulasmaa K; Salomaa V; Magnussen C; Iacoviello L; Di Castelnuovo A; Costanzo S; Linneberg A; Söderberg S; Zeller T; Ojeda-Echevarria FM; Blankenberg S; Westermann D
JACC Heart Fail; 2020 May; 8(5):401-411. PubMed ID: 32171759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
